237 related articles for article (PubMed ID: 34388383)
1. Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands.
Rao PPN; Shakeri A; Zhao Y; Calon F
Eur J Med Chem; 2021 Dec; 225():113753. PubMed ID: 34388383
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a
François-Moutal L; Felemban R; Scott DD; Sayegh MR; Miranda VG; Perez-Miller S; Khanna R; Gokhale V; Zarnescu DC; Khanna M
ACS Chem Biol; 2019 Sep; 14(9):2006-2013. PubMed ID: 31241884
[TBL] [Abstract][Full Text] [Related]
4. An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties.
Mollasalehi N; Francois-Moutal L; Scott DD; Tello JA; Williams H; Mahoney B; Carlson JM; Dong Y; Li X; Miranda VG; Gokhale V; Wang W; Barmada SJ; Khanna M
ACS Chem Biol; 2020 Nov; 15(11):2854-2859. PubMed ID: 33044808
[TBL] [Abstract][Full Text] [Related]
5. NMR Fragment-Based Screening against Tandem RNA Recognition Motifs of TDP-43.
Nshogoza G; Liu Y; Gao J; Liu M; Moududee SA; Ma R; Li F; Zhang J; Wu J; Shi Y; Ruan K
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262091
[TBL] [Abstract][Full Text] [Related]
6. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.
Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA
J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641
[TBL] [Abstract][Full Text] [Related]
7. Exploring the aggregation-prone regions from structural domains of human TDP-43.
Kumar V; Wahiduzzaman ; Prakash A; Tomar AK; Srivastava A; Kundu B; Lynn AM; Imtaiyaz Hassan M
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):286-296. PubMed ID: 30315897
[TBL] [Abstract][Full Text] [Related]
8. The Different Faces of the TDP-43 Low-Complexity Domain: The Formation of Liquid Droplets and Amyloid Fibrils.
Chien HM; Lee CC; Huang JJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360978
[TBL] [Abstract][Full Text] [Related]
9. Effective Inhibition of TDP-43 Aggregation by Native State Stabilization.
Yang L; Jasiqi Y; Zettor A; Vadas O; Chiaravalli J; Agou F; Lashuel HA
Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202314587. PubMed ID: 37949836
[TBL] [Abstract][Full Text] [Related]
10. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
11. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
Wei Y; Lim L; Wang L; Song J
Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
[TBL] [Abstract][Full Text] [Related]
12. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43.
Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M
PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using AlphaScreen technology.
Cassel JA; Blass BE; Reitz AB; Pawlyk AC
J Biomol Screen; 2010 Oct; 15(9):1099-106. PubMed ID: 20855563
[TBL] [Abstract][Full Text] [Related]
14. Zn
Preethi S; Bharathi V; Patel BK
Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
[TBL] [Abstract][Full Text] [Related]
15. Tethering-induced destabilization and ATP-binding for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1.
Dang M; Li Y; Song J
Sci Rep; 2021 Jan; 11(1):1034. PubMed ID: 33441818
[TBL] [Abstract][Full Text] [Related]
16. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
[TBL] [Abstract][Full Text] [Related]
19. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
20. A complex network of interdomain interactions underlies the conformational ensemble of monomeric TDP-43 and modulates its phase behavior.
Mohanty P; Rizuan A; Kim YC; Fawzi NL; Mittal J
Protein Sci; 2024 Feb; 33(2):e4891. PubMed ID: 38160320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]